CD86 and colorectal carcinoma: The expression of CD25, CD28, CD80, CD86, CD274 and CD279 immunoregulatory glycoproteins and the plasma levels of IL-1β, IL-2, IL-15 and TGFβ are altered in stage IV CRC patients receiving chemotherapy.